Cargando…
Health Disparities in the Immunoprevention of Human Papillomavirus Infection and Associated Malignancies
Human papillomavirus (HPV) causes roughly 1.6% of the plus 1.6 million cases of cancer that are diagnosed in the United States each year. Despite the proven safety and efficacy of available vaccines, HPV remains the most common sexually transmitted infection. Underlying the high prevalence of HPV in...
Autores principales: | Bakir, Amira H., Skarzynski, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682020/ https://www.ncbi.nlm.nih.gov/pubmed/26734596 http://dx.doi.org/10.3389/fpubh.2015.00256 |
Ejemplares similares
-
Cancer Immunoprevention and Public Health
por: Singh, Sandeep K., et al.
Publicado: (2017) -
Immunoprevention approaches for cancer prevention
por: Umar, Asad
Publicado: (2014) -
Costs related to immunopreventable diseases: Brazil and its geographic areas (immunopreventable diseases’ costs in Brazil)
por: da Costa, Élide Sbardellotto M., et al.
Publicado: (2021) -
Depiction of Vaginal Microbiota in Women With High-Risk Human Papillomavirus Infection
por: Wei, Zhen-Tong, et al.
Publicado: (2021) -
An Overview of Cancer Prevention: Chemoprevention and Immunoprevention
por: Gu, Kyle J., et al.
Publicado: (2020)